LENGTH OF SURVIVAL OF PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME IN THE UNITED-KINGDOM

[1] BENEDETTI J, 1983, BMDP STATISTICAL SOF

[2] BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.1093/biomet/57.3.579

[3] CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7

[4] DUBOIS RM, 1981, LANCET, V2, P1339

[5] FRIEDMANKIEN A, 1981, MMWR-MORBID MORTAL W, V30, P305

[6] KALBFLEISH JD, 1980, STATISTICAL ANAL FAI

[7] MOSS AR, 1984, J NATL CANCER I, V73, P1281

[8] QUINN A, 1985, CANADA DISEASES WEEK, V11, P114

[9] RIVIN BE, 1984, NEW ENGL J MED, V311, P857

[10] VADHANRAJ S, 1986, CANCER RES, V46, P417

[1] BENEDETTI J, 1983, BMDP STATISTICAL SOF

[2] BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.1093/biomet/57.3.579

[3] CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7

[4] DUBOIS RM, 1981, LANCET, V2, P1339

[5] FRIEDMANKIEN A, 1981, MMWR-MORBID MORTAL W, V30, P305

[6] KALBFLEISH JD, 1980, STATISTICAL ANAL FAI

[7] MOSS AR, 1984, J NATL CANCER I, V73, P1281

[8] QUINN A, 1985, CANADA DISEASES WEEK, V11, P114

[9] RIVIN BE, 1984, NEW ENGL J MED, V311, P857

[10] VADHANRAJ S, 1986, CANCER RES, V46, P417